IJRR

International Journal of Research and Review

| Home | Current Issue | Archive | Instructions to Authors | Journals |

Year: 2023 | Month: December | Volume: 10 | Issue: 12 | Pages: 126-131

DOI: https://doi.org/10.52403/ijrr.20231216

The Combination Therapy of Condyloma Acuminata Patient with Diabetes Mellitus: Case Report

Dewa Ayu Devi Anjaswari Putera1, Embun Dini Hari2

1Intern Doctor at Dermatology and Venereology Department, Klungkung General Hospital, Klungkung, Bali, Indonesia
2Dermatology and Venereology Department, Klungkung General Hospital, Klungkung, Bali, Indonesia

Corresponding Author: Dewa Ayu Devi Anjaswari Putera

ABSTRACT

Introduction: Condyloma acuminata with immunocompromised influences the choice of therapy and disease prognosis. This case report aims to provide an overview of the clinical outcome of condyloma acuminata in patients with diabetes mellitus.
Case report: Male, 53 years old, with a mass on the penis from the coronary sulcus to the glans penis, lesions resembling cauliflower. An acetowhite and histopathological investigation support the diagnosis of condyloma acuminata. Therapy with trichloroacetic acid (TCA) 90% and zinc sulfate monohydrate55mg/day. The lesions disappeared, and there were no new lesions after 2 weeks of treatment. There was no recurrence after 3 months of follow-up.
Discussion: There is no consensus governing the line of therapy for KA. So, there is no one therapy that is definitely ideal for all patients in general. Several previous studies used TCA and oral zinc with various doses and durations of therapy.
Conclusion: Giving TCA 90% every week and zinc sulfate monohydrate55mg/day gave satisfactory results in the treatment of condyloma acuminata with diabetes mellitus.

Keywords: Condyloma acuminata, diabetes mellitus, therapy

[PDF Full Text]